No Detail Found!

Role of Recombinant Activated Factor VIIa (rFVIIa) in Bleeding Mycotic Aneurysm of the Abdominal Aorta

Author(s)
Shaheen Bibi Department of Nephrology, Liaquat National Hospital,Karachi,Pakistan
Irfan Ahsan Department of Medicine, Liaquat National Hospital,Karachi,Pakistan
Karimullah Makki Department of Medicine, Liaquat National Hospital,Karachi,Pakistan
Sidra Rauf Department of Medicine, Liaquat National Hospital,Karachi,Pakistan
Abstract
Mycotic aortic aneurysm is an infective disease of the aorta with high mortality rate despite surgical repair. Recombinant activated factor VIIa (rFVIIa) is approved for the treatment of bleeding in hemophilia and used (o -labeled) in acute bleeding related to the trauma, cardiac surgery, and intracranial bleed. A 38-year female was admitted with abdominal pain, and was subsequently diagnosed with bleeding mycotic aneurysm of the abdominal aorta. She was given rFVIIa and the bleeding stopped successfully. We recommend further evaluation of the role of rFVIIa in bleeding mycotic abdominal aortic aneurysm, as it can bring a novel change in the management of this devastating disease.
Publication Details
Page(s) 1209-1211
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 9, Year: 2022

Request the full text from PASTIC

Keywords
bleeding, Factor VIIa (rFVIIa), Mycotic aortic aneurysm, Abdominal aorta
0

Citations

0

Downloads

63

Views